SeeFundsee funds clearly 🔍
Saved Sign in

PPH — VanEck Pharmaceutical ETF

Data as of 2026-09-21 · US · Sectors · window 2016-09-21 → 2026-09-21 (10.0 years) · returns assume dividends reinvested, net of fund fees · Market Data from Tiingo.com

What the history says

PPH
Total return+128.9%
Annualised (CAGR)+8.6%
Volatility (annualised)+14.9%
Sharpe (rf = 0)0.58
Deepest drawdown-29.7%
Drawdown peak → trough2020-02-12 → 2020-03-23

Over the 10.0 years to 2026-09-21 the fund returned +128.9% in total (+8.6% a year), with a deepest drawdown of -29.7% from 2020-02-12 to 2020-03-23. Its worst calendar year was 2016 (-10.4%), its best 2025 (+22.0%).

Every calendar year

Calendar-year returns (net of fees, dividends reinvested)
YearPPH
2026+9.7%
2025+22.0%
2024+8.1%
2023+6.9%
2022+2.6%
2021+17.8%
2020+5.5%
2019+19.4%
2018-5.9%
2017+15.2%
2016-10.4%

What this page does not say

It does not say PPH is a good or bad fund, and it is not a forecast. Returns above are history: they already include dividends and already exclude the fund's own fees. A drawdown of -29.7% means an investor who bought at the peak would have watched that much value disappear before it recovered — how long that takes is the part most tables leave out.

Run your own window, add fees or a second fund: open PPH in the tool. History is shown as history, never sold as a forecast.

More in US · Sectors: COPX · AIRR · AMLP · all fund pages